Carisma Therapeutics Inc. Quarterly Marketable Securities, Current in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Carisma Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2021 to Q4 2023.
  • Carisma Therapeutics Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$27.8M -100% Dec 31, 2023 10-K 2024-04-01
Q3 2023 $11M -$95.4M -89.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $40.7M -$28.7M -41.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $76.2M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $27.8M +$27.8M Dec 31, 2022 10-K 2024-04-01
Q3 2022 $106M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $69.5M Jun 30, 2022 10-Q/A 2022-08-25
Q4 2021 $0 Dec 31, 2021 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.